WorldWide Antimalarial Resistance Network Methodology Study Group, Dahal P, Simpson JA, Abdulla S, Achan J, et al.
2019-07-05 • Malaria Journal
2019-07-05 • Malaria Journal
BACKGROUND Therapeutic efficacy studies in uncomplicated Plasmodium falciparum malaria are confounded by new infections, which constitute competing risk events since they can potenti...
Mens PF, Van Overmeir C, Bonnet MMB, Dujardin JC, D'Alessandro U
2008-03-17 • Malaria Journal
2008-03-17 • Malaria Journal
BACKGROUND: Sulphadoxine-pyrimethamine has been abandoned as first- or second-line treatment by most African malaria endemic countries in favour of artemisinin-based combination treatmen...
van den Bogaart E, Berkhout MMZ, Nour AB, Mens PF, Talha AA, et al.
2013-04-11 • BMC Public Health
2013-04-11 • BMC Public Health
In areas where visceral leishmaniasis (VL) and malaria are co-endemic, co-infections are common. Clinical implications range from potential diagnostic delay to increased disease-related ...
van den Bogaart E, Berkhout MMZ, Adams ER, Mens PF, Sentongo E, et al.
2012-04-10 • PLOS Neglected Tropical Diseases
2012-04-10 • PLOS Neglected Tropical Diseases
Due to geographic overlap of malaria and visceral leishmaniasis (VL), co-infections may exist but have been poorly investigated. To describe prevalence, features and risk factors for VL-...
